Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
AllOne Health has acquired Carebridge EAP, Comp EAP, and ERC EAP, marking its 18th, 19th, and 20th acquisitions since 2016 to strengthen its nationwide Employee Assistance Program services.
UbiSim has introduced AI Narrative Analysis, a new feature that helps nursing educators quickly assess simulation data and provide targeted feedback, reducing review time by up to 90%.
Caris Life Sciences has entered a multi-year collaboration and license agreement with Genentech to identify and validate new oncology targets in solid tumors. The agreement includes $25 million in upfront and near-term payments and up to $1.1 billion in potential milestone payments.
OpenAI-backed biotech firm Chai Discovery has raised $130 million in Series B funding at a $1.3 billion valuation, led by General Catalyst and Oak HC/FT. The company’s Chai-2 platform uses AI to design new antibodies from scratch, improving success rates in drug discovery.
The Michael J. Fox Foundation for Parkinson’s Research has begun funding its first target validation projects under the multi-year Targets to Therapies Initiative, focusing on biological targets such as NOD2, OGA, and TRPML1 to advance new Parkinson’s treatments.
The U.S. Food and Drug Administration has launched an agentic AI system for internal use, allowing staff to automate complex tasks such as reviews, inspections, and meeting management. The system is hosted on a secure GovCloud environment and will operate under human oversight.
A peer-reviewed study by Medint published in Nature Scientific Reports found that large language models often overlook critical clinical nuances in complex medical scenarios, underperforming compared to human researchers.
Linus Health will present new data on its AI-enabled cognitive assessment tools at the Clinical Trials on Alzheimer’s Disease (CTAD) 2025 conference, highlighting their role in early detection and clinical trial efficiency.
Dastify Solutions’ 2025 Healthcare Billing Trends Report projects that AI-driven revenue cycle management could reduce claim denials by up to 40%, while manual workflows remain a major source of billing errors.
Dastify Solutions' 2025 Healthcare Billing Trends Report projects that AI-driven revenue cycle management could cut medical claim denials by up to 40%, highlighting automation and predictive analytics as key factors in improving efficiency.
Rad AI has launched a new speech recognition system designed to improve the speed and accuracy of radiology reporting through multi-model AI and contextual understanding.
MediView has received its first CE mark certification, allowing the company to introduce its mixed reality medical visualization system across Europe. The approval confirms compliance with EU safety and performance standards, enabling hospitals to use its augmented reality tools for image-guided procedures and remote collaboration.
ScreenPoint Medical is presenting its Transpara Breast AI suite at RSNA 2025, showcasing research that underscores its impact on cancer detection and workflow efficiency. The AI system, used in over 30 countries, has processed more than 11 million mammograms and is part of major clinical studies including MASAI and the upcoming PRISM trial.
InsiteOne announced new partnerships with ASCEND Cardiovascular and Apollo Enterprise Imaging to expand its enterprise imaging portfolio and improve interoperability across healthcare systems.
Anju Software has launched Luminee, an AI-powered engine that automates the creation of validated EDC databases, reducing clinical study build times from months to days.
Danish diabetes-tech company Hedia has appointed Rasmus Kofoed as its new CEO, effective December 1, 2025, succeeding Lars Christian Lund, who is stepping down after two years in the role.
Zentiva has introduced its first biosimilar monoclonal antibody in the European Union, marking the company's entry into the biosimilars market following EMA approval.
According to DataM Intelligence, the in-silico clinical trials market is expected to grow from $3.95 billion in 2024 to $6.39 billion by 2033, driven by AI-based modeling and virtual patient simulations.
AdvaHealth Solutions has unveiled AdvaPACS, a cloud-native and AI-enabled imaging platform designed to streamline radiology workflows with no upfront costs and flexible operational pricing.
Neuraxpharm and mjn-neuro announced plans to launch EPISERAS, an AI-powered wearable device designed to predict epileptic seizures in real time. The certified medical device uses a discreet earpiece sensor to monitor brain activity and alert users minutes before a potential seizure.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
